This HTML5 document contains 124 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1182/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q44211035
rdf:type
wikibase:Item
schema:description
vetenskaplig artikel 2002年学术文章 2002 թվականի նոյեմբերի 7-ին հրատարակված գիտական հոդված 2002년 논문 научна статия wetenschappelijk artikel 2002年學術文章 artikulong pang-agham articolo scientifico vědecký článek article scientific 2002年学术文章 scientific article published on 7 November 2002 bài báo khoa học 2002年學術文章 artigo científico article científic scientific article published on 7 November 2002 artículu científicu espublizáu en 2002 2002年学术文章 article scientifique 2002年の論文 مقالة علمية نشرت في 7 نوفمبر 2002 naučni članak 2002 nî lūn-bûn επιστημονικό άρθρο artikull shkencor 2002年学术文章 2002年學術文章 2002年学术文章 artigo científico научни чланак articol științific tieteellinen artikkeli научни чланак teaduslik artikkel artykuł naukowy מאמר מדעי мақолаи илмӣ vedecký článok artigo científico scientific article published on 7 November 2002 artículo científico publicado en 2002 wissenschaftlicher Artikel научная статья vitskapeleg artikkel 2002年學術文章 videnskabelig artikel bilimsel makale ৭ নভেম্বর ২০০২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ наукова стаття, опублікована в листопаді 2002 სამეცნიერო სტატია 2002年學術文章 บทความทางวิทยาศาสตร์ scienca artikolo 2002年学术文章 tudományos cikk artikel ilmiah vitenskapelig artikkel
p:P577
wds:Q44211035-CFE8228E-8A32-4D90-A749-8A13CF6664FF
wdt:P577
2002-11-07T00:00:00Z
p:P407
wds:Q44211035-DC11DCFA-A4C3-418B-B25A-A9AE50491A9C
wdt:P407
wd:Q1860
p:P2093
wds:Q44211035-F8AF76B4-6C50-4FDC-AEB5-286729CC83BB wds:Q44211035-ED5C83F8-9D9F-4165-AFE5-D47199A6AE6E wds:Q44211035-31EF044D-D480-4BFD-80D6-F3A56FDD1FB0 wds:Q44211035-7D146C1C-899D-49B2-8478-C5A18907AA74
wdt:P2093
Yu-Tzu Tai Charles Bailey Marie Joseph Xuesong Gu
rdfs:label
The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications
skos:prefLabel
The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications
schema:name
The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications
p:P50
wds:Q44211035-1BDFEB7D-E936-450C-B26A-46D154EB799A wds:Q44211035-48D52E8F-5E39-4AC5-87C7-BEC8C179F000 wds:Q44211035-6A865993-83D8-408C-95CE-68C586A3A8AB wds:Q44211035-7015D2B1-8FD1-49A7-AC1F-E50FA1A15CCF wds:Q44211035-896E8E18-75FC-4BA8-A6B8-4D155D2B4BFC wds:Q44211035-917A8D77-60DB-4C8B-9E7E-7F2A4C6E76AE wds:Q44211035-AD592BDB-8C7D-4B6C-8550-7EE0B05577A0 wds:Q44211035-BB844F47-3966-4E4F-A2FD-C4B4212DE859 wds:Q44211035-037A5F41-3C3C-450C-8EBD-DC113966A56A wds:Q44211035-047ED37E-4540-4FD7-B6BE-6AB665E13B40 wds:Q44211035-BF809815-FE2B-427E-AD8A-BA57B4755D69
wdt:P50
wd:Q44211150 wd:Q114300414 wd:Q117224765 wd:Q117224764 wd:Q117224720 wd:Q89228014 wd:Q87712102 wd:Q114455520 wd:Q28421846 wd:Q44211169 wd:Q117224711
p:P1476
wds:Q44211035-846B8787-BA51-4EF5-90CB-CAFEA385F5AF
wdt:P1476
The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications
p:P304
wds:Q44211035-83577367-4C74-42B8-9ED5-BA42480A60BE
wdt:P304
2377-2380
p:P31
wds:Q44211035-816BA812-E01A-4F74-90E3-B404AED5E749
wdt:P31
wd:Q13442814
p:P921
wds:Q44211035-CF8DD115-0F1D-4D5B-AF3B-710B661A6BD9 wds:Q44211035-17DC09FD-BD68-4B33-BCF2-95F45C1B5ACB
wdt:P921
wd:Q467635 wd:Q974135
p:P698
wds:Q44211035-37719610-B889-415F-A6DE-EF8708838A00
wdtn:P698
n9:12424198
wdt:P698
12424198
p:P1433
wds:Q44211035-D4DA942F-B2E3-4A1A-BC5F-F021B60AD69C
wdt:P1433
wd:Q885070
p:P433
wds:Q44211035-1072410D-0513-40C3-9235-F684E899550E
p:P478
wds:Q44211035-E195D6E2-B739-4463-9B3F-491B19AE2405
wdt:P433
6
wdt:P478
101
p:P1104
wds:Q44211035-8FBBABBB-2C86-49D7-A981-F783C09337E4
wdt:P1104
4
p:P356
wds:Q44211035-D8C984C1-A31C-422F-8FF2-16838179A772
wdtn:P356
n12:BLOOD-2002-06-1768
wdt:P356
10.1182/BLOOD-2002-06-1768